Evolent Health Revenue, Profits - EVH Annual Income Statement

Add to My Stocks
$24 $0.65 (2.78%) EVH stock closing price Aug 16, 2018 (Closing)

EVH stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Evolent Health stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $434.95M for 2017 impacts the EVH stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Evolent Health assets, operating expenses and Evolent Health free cash flow. The Evolent Health profit and loss statement shows revenue of $434.95M for 2017. Revenue has grown by 71.12% YOY for EVH stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
Evolent Health Revenues or Net Sales
434.95M254.18M96.87M100.88M40.28M
Cost Of Goods Sold (COGS)269.35M155.17M57.39M73.12M46.32M
Evolent Health Gross Profit
165.59M99.01M39.48M27.76M-6.04M
Research & Development Expense-----
Selling General & Admin Expense206.07M158.6M75.28M76.52M24.1M
Income Before Depreciation Depletion Amortization-40.47M-59.59M-35.8M-48.75M-30.14M
Depreciation Depletion Amortization32.36M177.82M7.16M3.69M1.83M
Non Operating Income--0.83M385.96M-0.01M-
Interest Expense3.63M-0.72M-0.29M-0.19M-
Evolent Health Pretax Income
-76.4M-237.53M343.28M-52.26M-32.8M
Provision for Income Taxes-6.63M-10.75M23.47M--
MinorityInterest-9.1M-67.03M-12.68M--
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-69.76M-226.77M319.81M-52.26M-32.81M
Extraordinary Items & Discontinued Operations-----
Evolent Health Profit/ Loss (Net Income)
-60.66M-159.74M332.49M-52.26M-32.81M
Average Shares used to compute Diluted EPS64.35M45.03M46.14M--
Average Shares used to compute Basic EPS64.35M45.03M25.13M--
Income Before Nonrecurring Items-45.24M-57.57M-79.83M--
Income from Nonrecurring Items-15.43M-102.18M412.33M--
Evolent Health Earnings Per Share Basic Net
-0.94-3.5513.14--
Evolent Health Earnings Per Share Diluted Net
-0.94-3.556.93--
EPS Diluted Before Nonrecurring Items-0.70-1.07-2.01--
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing Evolent Health stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $434.95M for this year of 2017. Our Evolent Health revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-60.66M for EVH stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The EVH financials along with Evolent Health historical stock prices provide a lot of details about the firm.

Evolent Health Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.66
Dividend Yield
0%